Exchange: NASDAQ·Updated 04:10 PM EST

MDWD News

News
all
press releases
MediWound Stock Earnings Estimates Raised by HC Wainwright
MediWound Ltd. (NASDAQ:MDWD - Free Report) - HC Wainwright boosted their FY2026 earnings per share estimates for MediWound in a report issued on Friday, November 13th. HC Wainwright analyst S. Ramakanth now forecasts that the biopharmaceutical company will post earnings of ($1.86) per share for the...
MarketBeat
MediWound Stock Earnings Estimates Raised by HC Wainwright
MediWound Ltd. (NASDAQ:MDWD - Free Report) - HC Wainwright boosted their FY2026 earnings per share estimates for MediWound in a report issued on Friday, November 13th. HC Wainwright analyst S. Ramakanth now forecasts that the biopharmaceutical company will post earnings of ($1.86) per share for the...
MarketBeat
More News
MediWound Ltd. (NASDAQ:MDWD - Free Report) - HC Wainwright lowered their FY2030 EPS estimates for MediWound in a research note issued on Friday, November 13th. HC Wainwright analyst S. Ramakanth now forecasts that the biopharmaceutical company will post earnings per share of $1.95 for the year, down...
MarketBeat
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
MediWound (NASDAQ:MDWD) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.Benzinga APIs provide real-time access to earnings callread more...
Benzinga
MediWound (MDWD) delivered earnings and revenue surprises of +1.52% and -53.15%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of +60.00% and +35.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Cronos (CRON) delivered earnings and revenue surprises of +33.33% and +33.68%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MediWound (MDWD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks
Madrigal (MDGL) delivered earnings and revenue surprises of +267.89% and +7.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
MediWound (MDWD) delivered earnings and revenue surprises of -1.32% and +19.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.